Screening for Research Participants
Launched by NATIONAL EYE INSTITUTE (NEI) · Apr 8, 2008
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Study Summary: Screening for Research Participants in Eye Diseases**
This clinical trial is designed to help doctors at the National Eye Institute (NEI) assess individuals with various eye diseases. The main goal is to find out if participants qualify for other NEI research studies. Importantly, this study does not involve any treatments; rather, it focuses on examining participants' eye health. People of all ages who have eye conditions — whether their diagnosis is known or unknown — may be eligible. This includes individuals with genetic eye diseases, eye movement issues, inflammation, and retinal diseases.
If you decide to participate, you can expect to undergo a series of tests to evaluate your eye condition. These tests may include a physical exam, blood tests (including genetic testing), eye exams to check vision and eye pressure, and questionnaires about your daily activities. Other procedures might involve taking samples from the eye, measuring how the retina responds to light, and capturing images of the blood vessels in your eyes. To be eligible, you should either have an eye disease, be a close relative of someone with an eye condition, or be a healthy volunteer. It’s essential that you can understand and agree to participate, and if you’re a minor, a parent or guardian will need to provide consent. This study could be a valuable opportunity to contribute to eye disease research while helping doctors understand these conditions better.
Gender
ALL
Eligibility criteria
- * INCLUSION CRITERIA:
- Participants will be able to enroll if they:
- • Have a diagnosed ocular disease/disorder; OR
- • Potentially have an unusual, interesting, or unknown ocular condition that requires the establishment of a diagnosis; OR
- • Potentially participate as a disease-free control participant in an NEI clinical research study; OR
- • Are an unaffected first-degree relative of a participant with either a diagnosed or undiagnosed ocular disorder; AND
- • Have the ability to understand and sign an informed consent OR if they are minor children have a legal parent/guardian with the ability to do the same.
- • Adults with impaired capacity to consent must have a Legally Authorized Representative (LAR) who is able to provide informed consent.
- EXCLUSION CRITERIA:
- Participants will be unable to enroll if they:
- • Are unwilling or unable to cooperate with the study procedures.
- • Female participants of childbearing potential who are pregnant are not eligible for enrollment.
About National Eye Institute (Nei)
The National Eye Institute (NEI), part of the U.S. National Institutes of Health (NIH), is dedicated to conducting and supporting innovative research to understand, prevent, and treat eye diseases and vision disorders. As a leading sponsor of clinical trials, NEI aims to advance knowledge in ocular health through rigorous scientific inquiry and collaboration with researchers, healthcare professionals, and institutions. By fostering the development of new therapies and technologies, NEI plays a pivotal role in enhancing the quality of life for individuals affected by visual impairments and eye conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
Bethesda, Maryland, United States
Patients applied
MH
BT

Trial Officials
Awilda V Holland, R.N.
Principal Investigator
National Eye Institute (NEI)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials